BANK VONTOBEL/PUT/ELI LILLY & CO/780/0.1/20.09.24 Share Price

Warrant

DE000VD0LA75

Delayed Deutsche Boerse AG 05:33:38 01/07/2024 pm IST
0.87 EUR -1.14% Intraday chart for BANK VONTOBEL/PUT/ELI LILLY & CO/780/0.1/20.09.24
Current month-73.41%
1 month-75.89%
Date Price Change
01/24/01 0.87 -1.14%
28/24/28 0.88 -8.33%
27/24/27 0.96 -6.80%
26/24/26 1.03 +5.10%
25/24/25 0.98 -7.55%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 05:33 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VD0LA7
ISINDE000VD0LA75
Date issued 19/02/2024
Strike 780 $
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 5.73
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 8.3
Lowest since issue 0.86
Delta-0.13x
Omega 12.35
Premium14.91x
Gearing94.64x
Moneyness 0.8615
Difference Strike -125.4 $
Difference Strike %-16.07%
Spread 0.02
Spread %2.22%
Intrinsic value 0.000000

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4 USD
Average target price
868.9 USD
Spread / Average Target
-4.03%
Consensus